Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Health professionals' willingness to pay and associated factors for human papilloma virus vaccination to prevent cervical cancer at College of Medicine and Health Sciences University of Gondar, Northwest Ethiopia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Tarekegn AA;Tarekegn AA; Yismaw AE; Yismaw AE
  • Source:
    BMC research notes [BMC Res Notes] 2019 Jan 24; Vol. 12 (1), pp. 58. Date of Electronic Publication: 2019 Jan 24.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Biomed Central, 2008.
    • Subject Terms:
    • Abstract:
      Objective: Preferences of health professionals' for human papilloma virus vaccines was measured by monetary value through willingness to pay (WTP) approach that could help policy makers set priorities among alternative cervical cancer prevention methods in poor countries. The objective of this study was to assess the female health professionals' willingness to accept and pay, and associated factors for human papilloma virus vaccination at College of Medicine and Health Sciences, University of Gondar, Northwest Ethiopia.
      Results: The majority (85.97%) of health professionals' were willing to pay for Human papilloma virus vaccine. On the average, the respondents were willing to pay 231.34 ETB (US$8.50) per human papilloma virus vaccination service. Age, educational status, knowledge about cervical cancer and its risk factors and monthly income were identified as significant factors to WTP for human papilloma virus vaccination. Policy makers shall consider human papilloma virus vaccine to prevent cervical cancer maintain health of women's and do more on rising awareness of individuals about cervical cancer and its risk factors.
    • References:
      Diabetes Care. 2006 Jun;29(6):1351-6. (PMID: 16732020)
      J Prev Med Public Health. 2006 Jul;39(4):331-8. (PMID: 16910307)
      Lancet. 2007 Jun 2;369(9576):1861-1868. (PMID: 17544766)
      J Health Popul Nutr. 2011 Jun;29(3):200-6. (PMID: 21766555)
      PLoS One. 2013 May 20;8(5):e64032. (PMID: 23700451)
      J Int Assoc Provid AIDS Care. 2015 May-Jun;14(3):241-4. (PMID: 23722087)
      BMC Health Serv Res. 2013 Jul 03;13:256. (PMID: 23822155)
      Int J Health Care Finance Econ. 2013 Dec;13(3-4):233-45. (PMID: 23996130)
      BMC Public Health. 2014 Mar 19;14:259. (PMID: 24642085)
      Asian Pac J Cancer Prev. 2015;16(14):5733-9. (PMID: 26320444)
      Cost Eff Resour Alloc. 2016 Jun 06;14:8. (PMID: 27274335)
      Iran J Pharm Res. 2017 Spring;16(2):823-833. (PMID: 28979338)
      Health Econ Rev. 2017 Nov 21;7(1):40. (PMID: 29159659)
    • Contributed Indexing:
      Keywords: Cervical cancer; Human papilloma virus; University of Gondar; Willingness to pay
    • Accession Number:
      0 (Papillomavirus Vaccines)
    • Publication Date:
      Date Created: 20190126 Date Completed: 20190502 Latest Revision: 20200225
    • Publication Date:
      20250114
    • Accession Number:
      PMC6346563
    • Accession Number:
      10.1186/s13104-019-4085-7
    • Accession Number:
      30678735